title: Tension-free vaginal tape, Burch, and slings: are there predictors for early postoperative voiding dysfunction?
abstract: This study compared the incidence, duration, and predictors of early postoperative voiding dysfunction (VD) after three continence operations. Charts of women undergoing tension-free vaginal tape (TVT), Burch, or suburethral sling were reviewed. Early postoperative VD was defined as urinary retention or postvoid residual (PVR) >200 ml at discharge. Analysis of variance, Chi-square, and non-parametric tests were used. Sixty-three TVT, 42 Burch and 33 slings were identified. Incidence of VD with TVT, sling, and Burch was 50, 24, and 15%, respectively ( P<0.001), and the mean number of days of postoperative catheter use was 9, 21, and 5 days, respectively ( P=0.04). Patients with VD, compared with those with normal voiding, had smaller preoperative PVR (50 vs. 75 ml, P=0.005), longer catheterization (29 vs. 3 days, P<0.001), and more urinary tract infections (43 vs. 15%, P<0.001). Early postoperative VD is an underreported but frequent postoperative complication which is difficult to predict.
authors.affiliation: Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, 700 University Ave, Toronto, Ontario, M5G 1Z5, Canada. vatche.minassian@utoronto.ca
authors.forename: Vatche A
authors.initials: VA
authors.lastname: Minassian
authors.forename: Ahmed
authors.initials: A
authors.lastname: Al-Badr
authors.forename: Harold P
authors.initials: HP
authors.lastname: Drutz
authors.forename: Danny
authors.initials: D
authors.lastname: Lovatsis
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D011379:Prognosis; D012189:Retrospective Studies; D013536:Suture Techniques; D016896:Treatment Outcome; D014546:Urinary Catheterization; D014550:Urinary Incontinence, Stress / Q000601:surgery*; D016055:Urinary Retention; D013520:Urologic Surgical Procedures / Q000009:adverse effects* / Q000379:methods*